标普和纳斯达克内在价值 联系我们

DNAPrint Genomics, Inc. DNAG OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
18/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

DNAPrint Genomics, Inc. (DNAG) 是一家上市公司 属于 医疗保健 板块,经营于 生物科技 行业. 公司总部位于 Sarasota, 美国. 现任CEO为 Jatin Patel.

DNAG 拥有 IPO日期为 2001-02-22, 24 名全职员工, 在 Other OTC, 市值为 $6.45K.

关于 DNAPrint Genomics, Inc.

DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.

📍 1621 West University Parkway, Sarasota
公司详情
所属板块医疗保健
细分行业生物科技
国家美国
交易所Other OTC
货币USD
IPO日期2001-02-22
首席执行官Jatin Patel
员工数24
交易信息
当前价格$0.00
市值$6.45K
52周区间0.000001-0.00002
Beta1.53
ETF
ADR
CUSIP23324Q202
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言